Mammoth Biosciences, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Mammoth Biosciences, Inc.
Quantité totale PI 148
Rang # Quantité totale PI 8 992
Note d'activité PI 3,1/5.0    190
Rang # Activité PI 3 528
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

55 0
5 3
82 2
1
 
Dernier brevet 2025 - Compositions and methods for mod...
Premier brevet 2002 - Seed planter
Dernière marque 2022 - MAMMOTH BIOSCIENCES
Première marque 2020 - MAMMOTH BIOSCIENCES

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Compositions and methods for modifying dux4. Provided herein are compositions, systems, and meth...
Invention Methods for quantitation of nucleic acid targets. Provided herein are compositions, systems, and...
Invention Fusion proteins and uses thereof for precision editing. Disclosed herein are composition and met...
2024 Invention Compositions and methods for circularizing donor nucleic acids. Disclosed herein are composition ...
Invention Compositions for the modification of the human nras and kras genes. Provided herein are composit...
Invention Effector proteins and uses thereof. Provided herein are compositions, systems, and methods compri...
Invention Engineered cas-phi proteins and uses thereof. Provided herein are compositions, systems, and met...
Invention Effector proteins and methods of use. Provided herein are compositions, systems, and methods com...
Invention Compositions and methods for modifying a human dystrophin gene. Provided herein are compositions...
Invention Compositions and methods for precision editing with cas dimers. Disclosed herein are systems, com...
Invention Devices, systems and methods for analysis of nucleic acids. Various compositions and diagnostic d...
Invention Instrumentation and methods for analysis of nucleic acids. The present disclosure provides variou...
Invention C9orf72 gene. C9ORF72C9ORF72 gene.
Invention Anti-crispr proteins. Provided herein are compositions, systems, and methods comprising anti-CRIS...
Invention Effector proteins, compositions, systems and methods of use thereof for the treatment of dmpk-ass...
Invention Compositions for the treatment of amyotrophic lateral sclerosis. SOD1SOD1 gene.
Invention Programmable nuclease-based assay improvements. The present disclosure describes various improve...
Invention Compositions and methods for the modification of human genes expressed by liver cells. Provided h...
Invention Compositions and methods for precise editing of human dystrophin. DMDDMD). Systems, compositions,...
Invention Car t cells generated by effector proteins and methods related thereto. Provided herein are vira...
Invention Systems and uses thereof for the treatment of dmd-associated diseases. Provided herein are compo...
Invention Programmable nucleases and methods of use. Provided herein, in certain embodiments, are programm...
Invention Effector proteins and uses thereof. Provided herein are compositions, systems, and methods compr...
Invention Large serine recombinases and methods of use. e.ge.g., a large serine recombinase (LSR)), a CRISP...
Invention Compositions and methods for targeted epigenetic modification. Provided herein are compositions, ...
Invention Effector protein compositions and methods of use thereof for manufacturing engineered hscs. Prov...
Invention Effector proteins, compositions, systems, devices, kits and methods of use thereof. Provided her...
Invention Effector proteins, compositions, systems and methods of use thereof. Provided herein are composit...
Invention Fusion effector proteins and uses thereof. The present disclosure provides compositions of CRISP...
Invention Engineered effector proteins, compositions, systems and methods of use thereof. Provided herein a...
Invention Ultracompact precision editing systems and uses thereof. Provided herein are compositions, system...
Invention Crispr systems targeting the braf gene relating to the treatment of melanoma. BRAFBRAFBRAF gene w...
Invention On cas template synthesis (ocats) systems and uses thereof. e.g.e.g., reverse transcriptases, or ...
Invention Compositions and methods for the modification and regulation of liver gene expression. APOC3 PCSK...
Invention Compositions for the treatment of spinal muscular atrophy. e.gSMN2SMN2 gene or the expression the...
Invention Methods and compositions for improved snp discrimination. Compositions and methods for improved ...
Invention Vectors encoding gene editing systems and uses thereof. Provided herein are viral vectors compri...
Invention Rna-directed protease systems and uses thereof. Provided herein are compositions, systems, and me...
2023 Invention Programmable nuclease diagnostic device. Various compositions and diagnostic devices for the det...
Invention Devices, systems, and methods for analysis of nucleic acids. The present disclosure provides var...
Invention Effector proteins and methods of use. The present disclosure provides compositions of effector p...
Invention Effector proteins, effector partners, compositions, systems and methods of use thereof. Provided...
Invention Methods and compositions for performing a detection assay. Described herein are methods, devices...
Invention Single-buffer compositions for nucleic acid detection. The present disclosure provides single-bu...
2022 P/S Scientific apparatus, namely, devices for detecting nucleic acids.. Medical devices for detecting...
Invention Programmable nuclease diagnostic device. The present disclosure provides various diagnostic devi...
P/S Enzymes for scientific and research purposes. Enzymes for use as a gene editor for therapeutics.
P/S Enzymes for scientific and research purposes, namely enzymes for use as a gene editor for therape...
2021 P/S Viral testing kits namely sets comprised of CRISPR-based reagents for testing bodily fluids for m...
P/S Viral testing kits namely sets comprised of CRISPR-based reagents for testing bodily fluids for ...
2020 P/S Scientific apparatus, namely, devices for detecting nucleic acids. Medical devices for detecting ...